Attached files
| file | filename |
|---|---|
| 10-Q/A - FORM 10-Q/A - Hubei Minkang Pharmaceutical Ltd. | v233617_10qa.htm |
| EX-31.1 - EXHIBIT 31.1 - Hubei Minkang Pharmaceutical Ltd. | v233617_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Hubei Minkang Pharmaceutical Ltd. | v233617_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Hubei Minkang Pharmaceutical Ltd. | v233617_ex32-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Hubei Minkang Pharmaceutical Ltd. | Financial_Report.xls |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q/A for the quarter ended June 30, 2011 of Hubei Minkang Pharmaceutical Ltd., a Nevada corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Hsien Loong Wong, President, CEO, CFO, Secretary, Treasurer and a director of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
|
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
Dated: August 26, 2011
|
/s/ Hsien Loong Wong
|
|
Hsien Loong Wong, President, CEO, CFO, Secretary,
Treasurer and a Director
|
|
|
(Principal Financial Officer)
|